UL Solutions Inc.

**Signal Note: Driehaus Capital initiates $64.5M ULS position** UL Solutions is a testing, inspection, and certification company with limited direct biotech exposure—this appears to be a portfolio diversification move rather than a biotech-specific thesis. The position size suggests Driehaus views ULS as undervalued in the broader market, possibly betting on margin expansion or M&A activity, but the signal carries minimal implications for drug development or clinical catalysts.